Scott D. Lee, MD

Digestive Health Center, University of Washington Medical Center

Poster(s):

• P4341 - Mirikizumab Improves Quality of Life in Patients With Moderately to Severely Active Crohn’s Disease: Results from the Phase 3 VIVID-1 Study
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET